Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis
March 19th, 2019
6.6K views
Here, we present a stepwise protocol to investigate the mitochondrial respiration and glycolytic function in Candida Albicans using an extra flux analyzer.
Overview
This protocol outlines a method to assess mitochondrial respiration and glycolytic function in Candida albicans using an extra flux analyzer. It enables the measurement of mitochondrial function without the need for purification.
Key Study Components
Area of Science
- Neuroscience
- Microbiology
- Cell Biology
Background
- Candida albicans is a common fungal pathogen.
- Understanding its metabolic pathways is crucial for developing treatments.
- Traditional methods require purification of mitochondria, complicating the analysis.
- This protocol simplifies the assessment of metabolic functions.
Purpose of Study
- To provide a straightforward method for measuring mitochondrial and glycolytic functions.
- To facilitate the investigation of genetic manipulations and chemical modulators.
- To enhance understanding of metabolic processes in fungal pathogens.
Methods Used
- Use of an extra flux analyzer for metabolic measurements.
- Optimization of cell number and mitochondrial inhibitor concentrations.
- Dissolving Poly-D-Lysine in tissue grid water for cell adhesion.
- Conducting experiments in a laminar flow hood for sterility.
Main Results
- The protocol allows for effective measurement of mitochondrial respiration.
- Glycolytic function can be assessed without purification steps.
- Results can inform on the effects of genetic and chemical interventions.
- Method is adaptable for other fungal species.
Conclusions
- This protocol is a valuable tool for studying Candida albicans metabolism.
- It simplifies the analysis of mitochondrial and glycolytic functions.
- Potential applications in research on fungal pathogens and treatments.
Frequently Asked Questions
What is the main advantage of this protocol?
The main advantage is that it allows for measuring mitochondrial function without purifying mitochondria.
Can this method be used for other organisms?
Yes, the method can be optimized for other fungal pathogens as well.
What is Poly-D-Lysine used for in this protocol?
Poly-D-Lysine is used to enhance cell adhesion on tissue culture surfaces.
Is this technique complex to perform?
No, the technique is relatively simple and straightforward.
What types of metabolic functions can be measured?
Both mitochondrial respiration and glycolytic function can be measured.
What conditions are necessary for performing this protocol?
Experiments should be conducted in a laminar flow hood to maintain sterility.
Executive Industry Relevance
This protocol enables direct measurement of mitochondrial respiration and glycolytic flux in Candida albicans without mitochondrial isolation, providing a scalable, physiologically relevant system for antifungal target validation. By linking metabolic phenotypes to genetic and pharmacological perturbations, it supports mechanistic de-risking of virulence and drug tolerance mechanisms in fungal pathogens. The assay delivers quantitative OCR and ECAR readouts that inform predictive confidence in lead compound effects on fungal bioenergetics.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Interrogates therapeutic hypotheses by measuring mitochondrial dysfunction in antifungal tolerance pathways.
- Scientific Value: Validates targets through genetic rescue (e.g., mam33 complementation) confirming phenotype specificity.
- Operational Value: Enables rapid screening of chemical modulators on OCR and ECAR in intact fungal cells.
Screening & Assay Development
- Scientific Value: Prepares standardized, adherent C. albicans cultures for reproducible extracellular flux measurements.
- Operational Value: Supports assay optimization via cell density and inhibitor titration for glycolytic and mitochondrial stress tests.
- Operational Value: Facilitates multiplexed readouts (OCR, ECAR) to distinguish respiratory compensation from glycolytic shifts.
Translational & Preclinical Research
- Scientific Value: Connects mitochondrial protein function (e.g., mam33) to virulence-associated metabolic inflexibility under glucose starvation.
- Scientific Value: Identifies metabolic dependencies that predict antifungal efficacy or tolerance development.
- Operational Value: Provides disease-relevant system for preclinical de-risking of metabolic inhibitors targeting fungal pathogens.
Pipeline & Workflow Integration
The method fits within antifungal discovery workflows from target hypothesis testing through lead optimization, enabling metabolic profiling at each stage to prioritize compounds with desired bioenergetic effects.
- Discovery Biology: Tests target engagement by linking mitochondrial or glycolytic inhibition to growth or virulence phenotypes.
- Screening: Delivers assay-ready, quantitative flux data for hit confirmation and structure-activity relationship modeling.
- Analytics: Generates OCR and ECAR kinetics that allow comparison of metabolic rewiring across strains and treatment conditions.
- Translational Research: Supports biomarker-like metabolic signatures (e.g., lack of glycolytic shift) predictive of target pathway essentiality.
- Enterprise Reuse: Establishes a reusable platform for metabolic screening across Candida spp. and other fungal pathogens.
Operational & Enterprise Impact
- Scientific Value: Reduces mechanistic ambiguity in antifungal action by resolving on-target metabolic effects.
- Operational Value: Eliminates mitochondrial isolation steps, increasing throughput and assay consistency.
- Strategic Value: Improves go/no-go decisions by identifying compounds that induce lethal metabolic inflexibility.
- Portfolio Impact: Enables risk-adjusted advancement of antifungals based on validated target engagement in pathogen-relevant systems.
Implementation Considerations
- Requires expertise in fungal culture, extracellular flux analysis, and handling of toxic inhibitors (e.g., potassium cyanide, antimycin A).
- Depends on Seahorse XF analyzer or equivalent flux instrumentation with compatible sensor cartridges.
- Necessitates standardization of Poly-D-Lysine coating, cell seeding density, and assay medium pH for reproducible adhesion and flux signals.
- Requires adaptation of inhibitor concentrations and incubation times across different Candida spp. or clinical isolates.
- Limited by the need for viable, adherent yeast cells; filamentous or biofilm forms may require protocol modification.
Biopharma FAQs
Why measure oxygen consumption rate for target validation in C. albicans?
Measuring OCR quantifies mitochondrial respiration, enabling direct assessment of target engagement when inhibitors disrupt the electron transport chain, as shown by potassium cyanide-induced shifts in wild-type strains.
How does isolating the independent variable (e.g., mam33 deletion) support antifungal discovery?
Genetic deletion of mam33 isolates its role in mitochondrial function, revealing that loss of this protein impairs compensatory glycolysis upon complex-IV inhibition, indicating a specific metabolic dependency.
What do extracellular acidification rate measurements enable in glycolytic stress testing?
ECAR quantifies glycolytic flux, allowing detection of compensatory glycolysis during mitochondrial inhibition and identifying strains unable to upregulate glycolysis under glucose starvation, as seen in the mam33 mutant.
Why are replication requirements critical for cross-functional collaboration in antifungal screening?
Replication ensures OCR and ECAR data are statistically robust and comparable across strains, treatments, and labs, enabling reliable interpretation of metabolic phenotypes in target validation campaigns.
What statistical analysis is required before implementing this assay in lead identification?
Baseline OCR and ECAR must be established with sufficient replicates to detect significant shifts upon inhibitor or genetic perturbation, using t-tests or ANOVA to confirm phenotype specificity, as demonstrated in the mam33 strain comparisons.
